The role of catalicedins in the development of infectious complications in hip replacement

Reducing the risk of infectious complications after hip replacement both in the early and late postoperative period remains an important task. Currently, there is a search for laboratory markers of infection development in the field of surgical intervention with high prognostic significance. Violation of the production of catelecidins LL37 may be a factor contributing to the development of infectious and inflammatory complications. To investigate the concentration of cathelicidin in dynamics in patients with hip replacement and the development of postoperative infectious complications.

Object and methods. A total of 49 people were examined, who were divided into three groups: the first group – 19 patients after hip replacement with no peculiarities during the postoperative period, the 2nd group – 15 patients after hip replacement: with the development of infection in the early stages (n = 6), and 9 patients with late deep complications within 1 year. The third group (n = 15) consisted of clinically healthy individuals. The results of a laboratory study of LL37 catelecidins in peripheral blood and drainage fluid were analyzed.

Results. As a result of the comparative analysis of the results obtained, certain patterns were revealed. Thus, the level of catelecidin in blood serum and drainage fluid in the group of patients with infectious complications was significantly higher than in the group of patients without complications. Blood loss during surgery may be an additional factor contributing to the disruption of the production of antimicrobial peptides. Discriminant analysis revealed that the determination of the level of cathelicidin on the 10th day after surgery and its content in the drainage fluid suggests the development of a postoperative complication in the form of a paraprosthetic infection.

1. 1 Sereda A.P., Kochish A.A., Chernyi A.A., Antipov A.P., Aliev A.G., Weber E.V., Vorontsova T.N., Bozhkova S.A., Shubnyakov I.I., Tikhilov R.M. Epidemiology of hip and knee replacement and periprosthetic infection in the Russian Federation. Traumatology and Orthopedics of Russia. 2021; 3: 84-92. (In Russ).

2. 2 Myasoedov A.A., Toropov S.S., Berezin G.V., Karelkin V.V., Totoev Z.A., Shubnyakov I.I., Tikhilov R.M. Risk factors for the development of periprosthetic infection after primary hip replacement. Traumatology and Orthopedics of Russia. 2020; 26 (1): 40-47. (In Russ).

3. 3 Mamonova I.A., Babushkina I.V., Puchinyan D.M. Etiological role of pathogens of infectious complications after arthroplasty of large joints. Fundamental'nye issledovaniya. 2015; 8(1):19–23. (In Russ).

4. 4 Tikhomirov D.A., Shchekolova N.B. Experience in the treatment of infectious complications after primary hip arthroplasty. Klinicheskie issledovaniya. 2016;23(4):28-32. (In Russ).

5. 5 Nguyen HLT, Trujillo-Paez JV, Umehara Y, Yue H, Peng G, Kiatsurayanon C, Chieosilapatham P, Song P, Okumura K, Ogawa H, Ikeda S, Niyonsaba F. Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis. Int J Mol Sci. 2020 Oct 14;21(20):7607. https://doi.org/10.3390/ijms21207607. PMID: 33066696; PMCID: PMC7589391.

6. 6 Konovalova M.V., Zubareva A.A., Lutsenko G.V., Svirshchevskaya E.V. Antimicrobial peptides are normal and in pathologies. Prikladnaya biohimiya i mikrobiologiya. 2018;54(3):236-243. (In Russ).

7. 7 Nagaoka I, Tamura H, Reich J. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model. Nagaoka I, Tamura H, Reich J. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model. https://doi.org/10.3390/ijms21175973. PMID: 32825174; PMCID: PMC7503894.

8. 8 Morozov A. N. The role of endogenous antimicrobial peptides in the development of infectious complications during hip replacement. VKR. FGBOU VO IGMU Minzdrava Rossii. 2020. (In Russ).

9. 9 Coorens M, Schneider VAF, de Groot AM, van Dijk A, Meijerink M, Wells JM, Scheenstra MR, Veldhuizen EJA, Haagsman HP. Cathelicidins Inhibit Escherichia coliInduced TLR2 and TLR4 Activation in a Viability-Dependent Manner. J Immunol. 2017 Aug 15;199(4):1418-1428. https://doi.org/10.4049/jimmunol.1602164. Epub 2017 Jul 14.PMID: 28710255; PMCID: PMC5544931.